Intracoronary Injection of CD133-Positive Enriched Bone Marrow Progenitor Cells Promotes Cardiac Recovery After Recent Myocardial Infarction | Zendy

Jozef Bartúnek | Zendy; Marc Vanderheyden | Zendy; Bart Vandekerckhove | Zendy; Samer Mansour | Zendy; Bernard De Bruyne | Zendy; Pieter De Bondt | Zendy; Inge Van Haute | Zendy; Nele Lootens | Zendy; Guy R. Heyndrickx | Zendy; William Wijns | Zendy

Open Access

Intracoronary Injection of CD133-Positive Enriched Bone Marrow Progenitor Cells Promotes Cardiac Recovery After Recent Myocardial Infarction

Author(s) -

Jozef Bartúnek,

Marc Vanderheyden,

Bart Vandekerckhove,

Samer Mansour,

Bernard De Bruyne,

Pieter De Bondt,

Inge Van Haute,

Nele Lootens,

Guy R. Heyndrickx,

William Wijns

Publication year - 2005

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.104.522292

Subject(s) - medicine , restenosis , myocardial infarction , progenitor cell , cardiology , ejection fraction , bone marrow , stent , perfusion , artery , infarction , ventricular remodeling , stem cell , heart failure , biology , genetics

Bone marrow CD133-positive (CD133+) cells possess high hematopoietic and angiogenic capacity. We tested the feasibility, safety, and functional effects of the use of enriched CD133+ progenitor cells after intracoronary administration in patients with recent myocardial infarction.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research